CW June 2002
Volume 11Issue Number 6 June 2002 ISSN 10593802 Letrozole Better than Anastrozole for Advanced Breast CancerThe first head-to-head comparison of two aromatase inhibitors (AI) shows that letrozole (Femara, Novartis) is slightly more effective than anastrozole (Arimidex, AstraZeneca) as a second-line treatment in postmenopausal women with advanced breast cancer.
Go to Previous Page Go to Next Page Source & Additional Reading ASCO Annual Meeting, Orlando. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
